Biomaterial Market By Type (Natural, Metallic, Polymeric, and Ceramic), By Application (Cardiovascular, Orthopaedic, Dental, Wound Healing, Plastic Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders, and Drug-Delivery Systems) and By Region – Trends, Analysis and Forecast till 2034

Biomaterial Market was valued at USD 145.0 Billion in 2024 and is projected to grow at a CAGR of 13.7% to reach USD 521.8 Billion by 2034

Biomaterials are broadly used in drug delivery as capsules or Nano-shells. Generally, they are biodegradable as well as bioresorbable so that they can disappear from organism after completing their function. Biomaterials are natural or synthetic in nature and regardless of their origin, they are compatible to be used in place of living tissues.

Biomaterials are substances which are natural or synthetic that interacts with biological system. These are nonviable materials used in order to make devices to replace a part or a function of the body in safe as well as physiologically acceptable manner. Synthetic biomaterials are made up of metallic, polymer, ceramics materials in the laboratories. Biomaterials are primarily used in the healthcare field. These materials are used for therapeutic and diagnostic purpose. Biomaterial has various end-use applications in various sectors. Metallic biomaterials are used in the dental applications while ceramic biomaterials are used in the tissue fixation.

Increasing use of biomaterials in the healthcare field for various applications is major factor driving growth of the global biomaterial market. In addition, growing advancements in the healthcare technologies is another factor supporting growth of the target market. Growing geriatric population, along with high prevalence of cardiovascular, neurological, & orthopaedic disorders across the globe are factors expected to propel growth of the market in the future. Moreover, increasing funding by government organizations in order to launch new biomaterial products, couple with rising awareness regarding advantages of biomaterials products among individuals are other factors expected to boost growth of the target market. However, high cost associated with the biomaterial production and occurrence of inflammatory responses owing to compatibility issues are expected to restrain growth of the market in the near future.

The major driving factor of the global biomaterials market are rising geriatric population, increasing cardiovascular diseases on rising side of index, and advancements in medicinal innovation. In addition, increasing government interests in research and development of biomaterials and growing demand for implant devices is also boosting growth of the target market. Moreover, high demand for biomaterials in wound healing technology and plastic surgery coupled with knee and hip replacement surgeries is driving growth of the global market. The rapidly growing healthcare sector is expected to drive the global biomaterials market in the future. Biomaterials have applications in various products, such as contact lenses, skin repair, blood vessel prosthesis, gene transfer, drug delivery, and dental. This is the primary factor expected to propel the growth of the global biomaterial market over the forecast time period. Moreover, the growing awareness about advanced technology, rising aging population base, increasing prevalence of chronic diseases are some other factors driving the biomaterials market globally. Furthermore, continuous research and development activities for bio inert and innovative material are anticipated to generate new growth opportunities for the biomaterials market in the future.  On the other hand, strict rules and regulations in medical fields, and unsuitable medical reforms in healthcare sectors are hampering the growth of the biomaterial market. High cost of biomaterial product is the major factors expected to restraint growth of the global target market. Whereas, increasing investments for material research is anticipated to create better opportunities for the biomaterials market.

Biomaterial market is segmented based on type of material, application, and region.

Based on type of material, the biomaterial market is segmented into the metallic biomaterials, ceramic biomaterials, polymeric biomaterials, and natural biomaterials. The metallic segment is expected to account significant revenue share in the global biomaterials market. The distinct properties of metallic biomaterials, such as strength, biocompatibility, and resistance to splintering, make them appropriate for several medical applications.  On the basis of application, the target market is bifurcated into cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, neurology, and other applications. In the application segmentation of the biomaterials market, orthopedics is believed to grow with the highest CAGR over the forecast period. The orthopedics application of biomaterials is majorly comprised of bone graft substitutes, which include allograft, autograft, demineralized bone matrix, bone morphogenetic proteins, cell-based matrices, and synthetic bone graft substitutes. For instance, BMP-2 (INFUSE), a recombinant DNA product, is one of the most renowned products by Medtronic that helps in faster fracture healing.

Based on the region the biomaterial market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is expected to account for the largest share of the global market due to rising biomaterial-based research, increasing demand for plastic surgeries, increasing conferences on biomaterials, and growing cancer incidence. Asia-Pacific region is expected to witness the highest growth market due to rising cosmetic and plastic surgeries in India coupled with lucrative medical device industry and new tax policy in China. In addition, growing number of cardiovascular diseases, increasing aging population, and rising volume of hip and knee replacement procedures in this region are also boosting growth of the target market in this region.

Biomaterial Market, By Type of Material:

• Metallic Biomaterials
• Ceramic Biomaterials
• Polymeric Biomaterials
• Natural Biomaterials

Biomaterial Market, By Application:

• Cardiovascular
• Orthopedic
• Ophthalmology
• Dental
• Plastic Surgery
• Wound Healing
• Tissue Engineering
• Neurology
• Other Applications

Biomaterial Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa Biomaterial Market, By Type of Material
    • Middle East & Africa Biomaterial Market, By Application
    • Middle East & Africa Biomaterial Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Biomaterial Market, By Type of Material
    • Latin America Biomaterial Market, By Application
    • Latin America Biomaterial Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific Biomaterial Market, By Type of Material
    • Asia Pacific Biomaterial Market, By Application
    • Asia Pacific Biomaterial Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • Europe Biomaterial Market, By Type of Material
    • Europe Biomaterial Market, By Application
    • Europe Biomaterial Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America Biomaterial Market, By Type of Material
  • North America Biomaterial Market, By Application
  • North America Biomaterial Market, By Country
    • U.S.
    • Canada

The key players operating the  biomaterial market involves Royal DSM, Medtronic, Berkeley Advanced Biomaterials, Inc., CAM Bioceramics BV, Celanese Corporation, Wright Medical Technology, Inc., Zimmer Biomet Holdings, Inc., Bayer AG, and Collagen Matrix. For instance, In July 2019, Royal DSM (Netherlands) entered into a partnership with ProMed Pharma (US). This partnership was aimed at developing novel sustained release drug delivery solutions in the polymeric drug delivery area. 

• Royal DSM
• Medtronic
• Berkeley Advanced Biomaterials, Inc.
• CAM Bioceramics BV
• Celanese Corporation
• Wright Medical Technology, Inc.
• Zimmer Biomet Holdings, Inc.
• Bayer AG
• Collagen Matrix.